The epidemiology of benign prostatic hyperplasia: a study in Greece

被引:0
作者
Signorello, LB
Tzonou, A
Lagiou, P
Samoli, E
Zavitsanos, X
Trichopoulos, D
机构
[1] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Publ Hlth, Ctr Canc Prevent, Boston, MA 02115 USA
[3] Univ Athens, Sch Med, Dept Hyg & Epidemiol, Athens, Greece
关键词
benign prostatic hyperplasia; epidemiology; risk factors; sexual activity;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective To assess the epidemiology of benign prostatic hyperplasia (BPH) in a case-control study in greater Athens, Greece. Patients and methods The study comprised 184 patients surgically treated For BPH within one year of its diagnosis (cases) and 246 patients with no symptoms of BPH who were treated in the same hospitals for minor diseases or conditions (controls). All cases and controls were permanent residents of the greater Athens area, Greece. The data were assessed using unconditional logistic regression. Results After controlling for age and education, cases and controls had similar distributions for height, body mass index, sibship size and birth order in the parental family, marital status, number of offspring and a series of previous medical diagnoses or surgical operations, The sole exception was surgery for haemorrhoids, that appeared to be related to the incidence of BPH, possibly by chance. There was no evidence that vertex baldness, tobacco smoking, alcohol consumption or coffee drinking increased the risk for BPH. Men who had spent most of their lives in a rural rather than an urban environment appeared to be at reduced risk for BPH. Conclusion The lifestyle factors assessed here have no major effect on the aetiology of BPH.
引用
收藏
页码:286 / 291
页数:6
相关论文
共 50 条
  • [31] Nutrition and benign prostatic hyperplasia
    Espinosa, Geovanni
    CURRENT OPINION IN UROLOGY, 2013, 23 (01) : 38 - 41
  • [32] Androgens and benign prostatic hyperplasia
    Mirone, V
    Fusco, F
    Verze, P
    Schulman, C
    Debruyne, F
    Imbimbo, C
    EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (04) : 410 - 417
  • [33] THERMOTHERAPY IN BENIGN PROSTATIC HYPERPLASIA
    HOFNER, K
    KRAH, H
    TAN, HK
    KUCZYK, M
    JONAS, U
    UROLOGE-AUSGABE A, 1995, 34 (01): : 16 - 24
  • [34] Management of Benign Prostatic Hyperplasia
    Kim, Eric H.
    Larson, Jeffrey A.
    Andriole, Gerald L.
    ANNUAL REVIEW OF MEDICINE, VOL 67, 2016, 67 : 137 - 151
  • [35] Treatment of Benign Prostatic Hyperplasia
    Pinheiro, Luis Campos
    Pisco, Joao Martins
    TECHNIQUES IN VASCULAR AND INTERVENTIONAL RADIOLOGY, 2012, 15 (04) : 256 - 260
  • [36] Silodosin for Benign Prostatic Hyperplasia
    Cantrell, Matthew A.
    Bream-Rouwenhorst, Heather R.
    Hemerson, Phyllis
    Magera, James S., Jr.
    ANNALS OF PHARMACOTHERAPY, 2010, 44 (02) : 302 - 310
  • [37] BENIGN PROSTATIC HYPERPLASIA: CLINICOPATHOLOGICAL STUDY OF 138 CASES
    Singh, Abhilash
    Ambedkar, Vivek
    Gaharwar, A. P. S.
    Singh, Vikas
    Rana, Dheer Singh
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2016, 5 (60): : 4198 - 4203
  • [38] FUROSEMIDE USE AND HOSPITALIZATION FOR BENIGN PROSTATIC HYPERPLASIA
    Delaney, J. A. C.
    Levesque, L. E.
    Etminan, M.
    Suissa, S.
    JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY, 2006, 13 (01): : E75 - E80
  • [39] Prostatic stents for the treatment of benign prostatic hyperplasia
    VanderBrink, Brian A.
    Rastinehad, Ardeshir R.
    Badlani, Gopal H.
    CURRENT OPINION IN UROLOGY, 2007, 17 (01) : 1 - 6
  • [40] Benign prostatic hyperplasia and urolithiasis
    Krombach P.
    Michel M.S.
    Der Urologe, 2010, 49 (Suppl 1): : 149 - 153